Alimera Sciences, Inc.
ALIM · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $27,000 | $23,011 | $26,306 | $23,364 |
| % Growth | 17.3% | -12.5% | 12.6% | – |
| Cost of Goods Sold | $3,831 | $3,353 | $3,626 | $2,758 |
| Gross Profit | $23,169 | $16,573 | $22,680 | $17,446 |
| % Margin | 85.8% | 72% | 86.2% | 74.7% |
| R&D Expenses | $4,263 | $4,361 | $4,769 | $4,045 |
| G&A Expenses | $7,379 | $5,432 | $6,379 | $3,607 |
| SG&A Expenses | $15,875 | $14,514 | $14,147 | $11,547 |
| Sales & Mktg Exp. | $8,511 | $9,082 | $7,768 | $7,940 |
| Other Operating Expenses | $0 | $3,085 | -$1,083 | $402 |
| Operating Expenses | $20,138 | $21,960 | $18,455 | $15,994 |
| Operating Income | -$77 | -$2,302 | $724 | $1,854 |
| % Margin | -0.3% | -10% | 2.8% | 7.9% |
| Other Income/Exp. Net | -$3,277 | -$3,981 | -$4,498 | -$3,155 |
| Pre-Tax Income | -$3,354 | -$6,283 | -$3,774 | -$1,301 |
| Tax Expense | -$43 | -$32 | $7 | $53 |
| Net Income | -$3,311 | -$6,251 | -$3,781 | -$1,354 |
| % Margin | -12.3% | -27.2% | -14.4% | -5.8% |
| EPS | -0.061 | -0.11 | -0.07 | -0.042 |
| % Growth | 44.6% | -58.3% | -64.7% | – |
| EPS Diluted | -0.061 | -0.11 | -0.07 | -0.042 |
| Weighted Avg Shares Out | 54,384 | 54,357 | 54,423 | 32,106 |
| Weighted Avg Shares Out Dil | 54,384 | 54,357 | 54,423 | 32,106 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,153 | $3,739 | $4,754 | $2,070 |
| Depreciation & Amortization | $3,093 | $3,085 | $3,040 | $3,160 |
| EBITDA | $2,892 | $541 | $4,020 | $3,929 |
| % Margin | 10.7% | 2.4% | 15.3% | 16.8% |